PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2014 | 12 | 10 | 1047-1055
Article title

Synthesis and antiproliferative activity in vitro of new 2-aminobenzimidazole derivatives. Reaction of 2-arylideneaminobenzimidazole with selected nitriles containing active methylene group

Content
Title variants
Languages of publication
EN
Abstracts
EN
A series of pyrimido[1,2-a]benzimidazole and α-cyanocinnamic acid derivatives have been synthesized in the reactions of Schiff bases 2–7 with selected nitriles containing an active methylene group: malononitrile 8–12, cyanoacetamide 13–16, benzyl cyanide 17–21, benzoylacetonitrile 22–24, cyanoacetate methyl ester 25–28 and benzylacetamide 29. The structures 8–29 were confirmed by the results of elementary analysis and their IR, 1H-, 13C-NMR and MS spectra. The products 8–29 of various chemical structure pyrimido[1,2-a] benzimidazole 8–12, 14–16, 17–21, 23–24, 26 and α-cyanocinnamic acid derivatives 13, 22, 25, 27, 28 were obtained, which are of interest for biological studies or which can be substrates for further synthesis. The selected compounds 10, 13, 14, 17, 19, 21, 23–25 and 28 were screened for their antiproliferative activity in vitro against neoplastic and normal cell lines. The most active two compounds were: 2-(o-bromophenylene)-3-cyano-4-phenyl-1,2-dihydropyrimido[1,2-a]benzimidazole (24) and 3-cyano-4-phenyl-2-(2,4-dimethoxyphenyl)-1,2-dihydropyrimido[1,2-a]benzimidazole (23). However, similarly like cisplatin used as the control, they showed no selectivity towards cancer cells, by inhibiting proliferation of normal mouse fibroblasts in similar manner.
Publisher

Journal
Year
Volume
12
Issue
10
Pages
1047-1055
Physical description
Dates
published
1 - 10 - 2014
online
15 - 5 - 2014
Contributors
author
  • Wroclaw Medical University
  • Wroclaw Medical University
  • Polish Academy of Science
  • Polish Academy of Science
author
  • Wroclaw Medical University
References
  • [1] The Merck Index, 14th edition (Whitehouse Station, USA, 2006)
  • [2] V.A. Anisimova, M.M. Osipova, A.A. Spasov, A.F. Turchaeva, G.P. Dudchenko, N.P. Larionov, S.G. Kovalcv, Pharm. Chem. J. 36, 468 (2002) http://dx.doi.org/10.1023/A:1021888520874[Crossref]
  • [3] A. Settimo, G. Primofiore, F. Settimo, A.M. Marini, Il Farmaco 47, 1293 (1992)
  • [4] J.P. Powers, S. Li, J.C. Jaen, J. Liu, N.P.C. Walker, Z. Wang, H. Wesche, Bioorg. Med. Chem. Lett. 16, 2842 (2006) http://dx.doi.org/10.1016/j.bmcl.2006.03.020[Crossref]
  • [5] P.F. Asobo, H. Wahe, J.T. Mbafor, A.E. Nkengfack, Z.T. Fomum, E.F. Sophue, D. Döpp, J. Chem. Soc. Perkin Trans. 1, 457 (2001) http://dx.doi.org/10.1039/b005511p[Crossref]
  • [6] J. Madden, J.R. Dod, R. Godemann, J. Kraemer, M. Smith, M. Biniszkiewicz, D.J. Hallett, J. Barker, J.D. Dyekjaer, T. Hesterkamp, Bioorg. Med. Chem. Lett. 20, 5329 (2010) http://dx.doi.org/10.1016/j.bmcl.2010.06.089[Crossref]
  • [7] P.P. Seth, E.A. Jefferson, L.M. Risen, S.A. Osgood, Bioorg.Med. Chem. 13, 1669 (2003) http://dx.doi.org/10.1016/S0960-894X(03)00245-2[Crossref]
  • [8] S.O. Podunavac-Kuzmanović, D.D. Cvetkovic, CI&CEQ 17, 9 (2011) http://dx.doi.org/10.2298/CICEQ100329044P[Crossref]
  • [9] T.A. Farghaly, N.A.A. Hafez, E.A. Ragab, H.M. Awad, M.M. Abdalla, Eur. J. Med. Chem. 45, 492 (2010) http://dx.doi.org/10.1016/j.ejmech.2009.10.033[Crossref]
  • [10] W.P. Nawrocka, Boll. Chim. Farm. 135, 18 (1996)
  • [11] W.P. Nawrocka, A. Nowicka, H. Liszkiewicz, Wiad. Chem. 66, 811 (2012) (in Polish)
  • [12] W.P. Nawrocka, A. Nowicka, H. Liszkiewicz, Wiad. Chem. 66, 839 (2012) (in Polish)
  • [13] W.P. Nawrocka, A. Nowicka, Wiad. Chem. 67, 715 (2013) (in Polish)
  • [14] A. Nowicka, W.P. Nawrocka, Wiad. Chem. 67, 695 (2013) (in Polish)
  • [15] A. Nowicka, W.P. Nawrocka, Wiad. Chem. 67, 203 (2013) (in Polish)
  • [16] W.P. Nawrocka, B. Sztuba, A. Dryś, J. Wietrzyk, J. Kosendiak, A. Opolski, Pol.J.Chem., 80, 279 (2006)
  • [17] W.P. Nawrocka, M.W. Kowalska, B. Sztuba, A. Dryś, J. Wietrzyk, B. Filip, Pol. J. Chem. 81, 1753 (2007)
  • [18] W.P. Nawrocka, B. Sztuba, M.W. Kowalska, H. Liszkiewicz, J. Wietrzyk, A. Nasulewicz, M. Pełczyńska, A. Opolski, Il Farmaco 59, 83 (2004) http://dx.doi.org/10.1016/j.farmac.2003.12.001[Crossref]
  • [19] M. Rai, S. Kumar, K. Krishan, A. Singh, Indian J. Chem. 17B, 287 (1979)
  • [20] M. Rai, K. Krishan, A. Singh, Indian J. Chem. 13, 991 (1975)
  • [21] F.A. Bassyouni, I.I. Ismail, Afinidad LVIII, 375, (2001)
  • [22] M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, J.A. Montgomery, Jr., T. Vreven, K.N. Kudin, J.C. Burant, J.M. Millam, S.S. Iyengar, J. Tomasi, V. Barone, B. Mennucci, M. Cossi, G. Scalmani, N. Rega, G.A. Petersson, H. Nakatsuji, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, M. Klene, X. Li, J.E. Knox, H.P. Hratchian, J.B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R.E. Stratmann, O. Yazyev, A.J. Austin, R. Cammi, C. Pomelli, J.W. Ochterski, P.Y. Ayala, K. Morokuma, G.A. Voth, P. Salvador, J.J. Dannenberg, V.G. Zakrzewski, S. Dapprich, A.D. Daniels, M.C. Strain, O. Farkas, D.K. Malick, A.D. Rabuck, K. Raghavachari, J.B. Foresman, J.V. Ortiz, Q. Cui, A.G. Baboul, S. Clifford, J. Cioslowski, B.B. Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R.L. Martin, D.J. Fox, T. Keith, M.A. Al-Laham, C.Y. Peng, A. Nanayakkara, M. Challacombe, P.M.W. Gill, B. Johnson, W. Chen, M.W. Wong, C. Gonzalez, J.A. Pople, Gaussian 03, Revision C.02 (Gaussian, Inc., Wallingford, CT, 2004)
  • [23] J. Wietrzyk, M. Chodynski, H. Fitak, E. Wojdat, A. Kutner, A. Opolski, Anticancer Drugs 18, 447 (2007) http://dx.doi.org/10.1097/CAD.0b013e3280143166[Crossref]
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.-psjd-doi-10_2478_s11532-014-0533-3
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.